Company Profiles

driven by the PitchBook Platform

Glycos Biotechnologies

Description

Developer of bacterial strains used for producing chemicals and biofuels. The company develops microorganisms that can convert low value by product feedstock sources such as crude glycerin, gums and fatty acids into higher value green chemicals.

2007

Founded

PRIVATE

Status

11-50

Employees

Conv. Debt

Latest Deal Type

$560k

Latest Deal Amount

$20.1M

Total Amount Raised

Description

Developer of bacterial strains used for producing chemicals and biofuels. The company develops microorganisms that can convert low value by product feedstock sources such as crude glycerin, gums and fatty acids into higher value green chemicals.

Website:

www.glycosbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Industrial Chemicals

Other Industries

Other Chemicals and Gases

Primary Office

711 Leverkuhn Street Houston, TX 77007United States +1 (713) 869-9377
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Glycos Biotechnologies's full profile, request a free trial.

Glycos Biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Glycos Biotechnologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Glycos Biotechnologies Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Daniel JaniakAngel (individual)Minority000 0000000 0000
Draper Fisher JurvetsonVenture CapitalMinority000 0000000 0000
Draper NexusVenture CapitalMinority000 0000000 0000
EIV CapitalPE/BuyoutMinority000 0000000 0000
Frank FosterAngel (individual)Minority000 0000000 0000
Daniel Janiak Angel (individual)
Draper Fisher Jurvetson Venture Capital
Draper Nexus Venture Capital
EIV Capital PE/Buyout
Frank Foster Angel (individual)

Glycos Biotechnologies Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Richard Cilento Jr.Chief Executive Officer & Chairman
Walter BurnapPresident, Chief Financial Officer and Board Member
Paul Campbell Ph.DChief Science Officer
Kevin MitchellVice President, Finance
Werner Bussmann Ph.DVice President, Program Management
Richard Cilento Jr. Chief Executive Officer & Chairman
Walter Burnap President, Chief Financial Officer and Board Member
Paul Campbell Ph.D Chief Science Officer
Kevin Mitchell Vice President, Finance
Werner Bussmann Ph.D Vice President, Program Management

Glycos Biotechnologies Board Members (5)

NameRepresentingRoleSinceContact
Info
Daniel Watkins Ph.DMercury FundBoard Member000 0000
Gary MossmanSelfBoard Member000 0000
Richard Cilento Jr.Glycos BiotechnologiesChief Executive Officer & Chairman000 0000
Stephen JurvetsonDraper Fisher JurvetsonBoard Member000 0000
Walter BurnapGlycos BiotechnologiesPresident, Chief Financial Officer and Board Member000 0000
Daniel Watkins Ph.D Board Member Mercury Fund
Gary Mossman Board Member Self
Richard Cilento Jr. Chief Executive Officer & Chairman Glycos Biotechnologies
Stephen Jurvetson Board Member Draper Fisher Jurvetson
Walter Burnap President, Chief Financial Officer and Board Member Glycos Biotechnologies
Request full access to PitchBook